<DOC>
	<DOCNO>NCT00080912</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . It yet know whether single-fraction ( single-dose ) re-irradiation therapy effective multiple-fraction ( many small dos radiation therapy ) re-irradiation therapy relieve bone pain cause bone metastasis . PURPOSE : This randomized phase III trial study single-dose radiation therapy see work well multiple-dose radiation therapy treat patient previously irradiate painful bone metastasis .</brief_summary>
	<brief_title>Single-Fraction Compared With Multiple-Fraction Therapy Treating Patients With Previously Irradiated Painful Bone Metastases</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare pain relief patient undergo single-fraction vs multiple-fraction re-irradiation painful bone metastases 2 month treatment . Secondary - Compare overall pain relief patient treat regimen . - Compare time pain progression patient treat regimen . - Assess relationship response initial radiation pain relief re-irradiation patient . - Compare change functional interference re-irradiation use Brief Pain Inventory patient treat regimen . - Compare quality life patient treat regimen ( patient Canada , France , Netherlands , patient register RTOG ) . - Determine characteristic non-responders ( initial re-irradiation ) among patient treat regimen . - Monitor incidence acute severe radiation-related side effect patient treat regimen . - Monitor incidence in-field pathological fracture spinal cord compression patient treat regimen . OUTLINE : This randomize , multicenter study . Patients stratify accord response initial radiotherapy ( yes v ) , initial fractionation ( single fraction v multiple fraction ) , participate center . Patients randomize 1 2 treatment arm . - Arm I : Patients receive single-fraction radiotherapy ( 8Gy ) day 1 . - Arm II : Patients receive multiple-fraction radiotherapy ( total 20Gy ) 5 day 8 day re-irradiation spine and/or whole pelvis involve AND prior initial radiotherapy give multiple fraction . At least 4 week first re-treatment , patient arm may receive second re-treatment discretion treat oncologist . Patients complete Brief Pain Inventory questionnaire baseline , day 7 14 , monthly month 1-6 , month 9 12 . Acute Toxicities assess day 7 14 . Quality Life assess baseline monthly month 1-6 patient participate group . Patients follow 1 year . Peer Reviewed Funded Endorsed Cancer Research UK PROJECTED ACCRUAL : A total 850 patient accrue study .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm malignancy Diagnosis needle biopsy , bone marrow biopsy , cytology , surgical biopsy resection Bone metastases clinically painful area confirm follow : Plain radiographs Radionuclide bone scan CT scan Magnetic resonance image Worst pain score ≥ 2/10 use baseline Brief Pain Inventory Pain arise previously irradiate metastasis progressive disease adjoin remote area Initial radiotherapy field reproducible reirradiation Current treatment field palliative radiotherapy must size small initial treatment field No clinical radiological evidence pathological fracture target site extremity . No radiological evidence highrisk lesion pathological fracture extremity ( lytic lesion &gt; 3cm &gt; 50 % cortical erosion bone diameter ) target site AND patient candidate surgical intervention . No clinical radiological evidence spinal cord compression target site . PATIENT CHARACTERISTICS : Age 18 Performance status Karnofsky 50100 % Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Not pregnant nursing Fertile patient must use effective barrier contraception Able willing complete quality life questionnaire English , French , Dutch , Spanish ( randomize Canadian , Dutch , French RTOG centre ) Must accessible treatment followup Informed consent PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy See Disease Characteristics No 1 prior course radiotherapy target site No prior radiotherapy dose ≥ 24 Gy 6 fraction , 27 Gy 8 fraction , 30 Gy 10 fraction spine part pelvis encompass small large bowel and/or rectum , site treat study Initial dose 24 Gy 6 fraction , 27 Gy 8 fraction 30 Gy 10 fraction acetabulum hip proximal femur allow long medial field border initial treatment cross midline No prior radiotherapy dose &gt; 30Gy 10 fraction ribs extremity site treat study More 30 day since prior strontium chloride Sr 89 More 30 day since prior halfbody radiotherapy , include current reirradiation field At least 4 week since initial radiotherapy Surgery No prior palliative surgery treatment area No concurrent surgical intervention treatment area Other No prior participation protocol No plan make immediate change analgesic regimen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>bone metastasis</keyword>
	<keyword>pain</keyword>
</DOC>